Japan Vascular Surgery and Endovascular Procedures Market Size
The Japan vascular surgery and endovascular procedures market reached US$ 131.60 Million in 2024 and is expected to reach US$ 263.94 Million by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033.
Japan Vascular Surgery and Endovascular Procedures Market Overview
The Japan vascular surgery and endovascular procedures market has demonstrated robust growth, reflecting the country’s evolving healthcare needs and technological advancements. Japan’s rapidly aging population is a primary driver of market growth. Over a third of the population is aged 65 or older, and more than one in ten is over 80. This demographic shift increases the prevalence of vascular diseases such as peripheral arterial disease (PAD), aortic aneurysms, varicose veins, and stroke, all of which require vascular interventions. Innovations in minimally invasive endovascular procedures, including advanced stents, drug-eluting balloons, and robotic-assisted navigation, have improved the safety, efficiency, and accessibility of treatments. This has led to increased adoption of these procedures across Japan.
Japan Vascular Surgery and Endovascular Procedures Market Executive Summary
Japan Vascular Surgery and Endovascular Procedures Market Dynamics: Drivers & Restraints
The rising aging population is significantly driving the Japan vascular surgery and endovascular procedures market growth
According to the World Economic Forum, Japan is getting ever greyer. More than 1 in 10 people in the country are now aged 80 or older. Almost a third of its population is over 65 – an estimated 36.23 million. Stroke risk rises with age, particularly due to carotid artery disease, which is a common vascular condition in older people. Japan’s rising aging population is a major driver of growth in the vascular surgery and endovascular procedures market due to the strong correlation between advanced age and the prevalence of vascular diseases.
With more elderly patients, there is a growing need for both traditional vascular surgeries and minimally invasive endovascular procedures. The elderly are particularly susceptible to complications from vascular disease, making timely intervention critical. The crude mortality rate from cardiovascular diseases (including stroke and coronary heart disease) has remained significant, even as age-adjusted rates have declined due to improved treatments and prevention. The sheer number of elderly individuals, projected to reach over 36% of the population by 2045, means a sustained and expanding demand for vascular procedures.
High costs associated with vascular surgery and endovascular procedures are hampering the growth of the Japan vascular surgery and endovascular procedures market
The cost of Endovascular Aneurysm Repair (EVAR), which requires specialized grafts and imaging equipment, can be significantly higher than traditional surgery. For instance, according to the Oxford Academy, the average medical cost for EVAR was 35,2000 Japanese Yen per patient.
Additionally, according to a study conducted by the National Institute of Health, the mean costs for open surgical repair (OR) versus EVAR were as follows, Diagnosis Procedure Combination (DPC) ¥632,370 versus ¥490,050, respectively, which was significant; anesthesia, ¥123,540 versus ¥86,220, respectively and materials, ¥257,770 versus ¥2,113,280, respectively. Thus, the mean total cost was ¥1,825,830 versus ¥3,159,270 for open repair and EVAR, respectively.
Despite Japan’s universal health insurance system, which caps out-of-pocket expenses, the high upfront costs of these procedures still place a considerable burden on the healthcare system and, indirectly, on patients through higher insurance premiums or government subsidies. The government has even considered raising the cap on out-of-pocket expenses for patients, which could further discourage utilization if not managed carefully.
For more details on this report – Request for Sample
Japan Vascular Surgery and Endovascular Procedures Market, Segment Analysis
The Japan vascular surgery and endovascular procedures market is segmented based on procedure, product type, and end-user.
The endovascular repair from the procedure segment is expected to hold 31.67% of the market share in 2024 in the Japan vascular surgery and endovascular procedures market
Patients and physicians increasingly favor endovascular procedures over traditional open surgery because they require only small incisions or punctures, resulting in less trauma, faster recovery, and shorter hospital stays. Innovations in stent grafts, drug-eluting balloons, and robotic-assisted navigation have made endovascular repair safer, more efficient, and accessible. The integration of advanced imaging and navigation technologies further enhances the precision and outcomes of these procedures.
The rising prevalence of vascular diseases among Japan’s large elderly population has increased demand for effective, less invasive treatments. Older patients, who often have comorbidities, benefit significantly from the reduced risk and quicker recovery associated with endovascular repair. The endovascular repair segment holds a major portion of the market share and is expected to continue dominating due to ongoing advancements and patient preference. For instance, according to the study conducted by the National Institute of Health, among the 20,160 cases of AAA registered by the Japanese Society for Vascular Surgery, 61.6% were treated with EVAR, highlighting its mainstream adoption.
Japan Vascular Surgery and Endovascular Procedures Market Competitive Landscape
The major Japan players in the vascular surgery and endovascular procedures market include Terumo Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Mizuho Medical Co., Ltd., Nipro Corporation, Shimadzu Corporation, SB-KAWASUMI LABORATORIES, INC., ASAHI INTECC CO., LTD., Medtronic plc, and Boston Scientific Corporation, among others.
Japan Vascular Surgery and Endovascular Procedures Market Scope
Metrics | Details | |
CAGR | 8.1% | |
Market Size Available for Years | 2022-2033 | |
Estimation Forecast Period | 2025-2033 | |
Revenue Units | Value (US$ Mn) | |
Segments Covered | Procedure | Aneurysm Repair, Bypass Surgery, Carotid Angioplasty and Stenting, Endovascular Repair, Others |
Product Type | Stents and Stent Grafts, Endovascular Tools, Scissors and Forceps, Needle Holders, Others | |
End-User | Hospitals, Surgical Centers, Academic and Research Institutions, Others | |
The Japan vascular surgery and endovascular procedures market report delivers a detailed analysis with 39 key tables, more than 31 visually impactful figures, and 147 pages of expert insights, providing a complete view of the market landscape.
